Results 1 to 10 of about 14,449 (134)

Examination of Lower Limb Microcirculation in Diabetic Patients with and without Intermittent Claudication [PDF]

Biomedicines, 2023
Intermittent claudication is a frequent complaint in lower extremity artery disease, but approximately two thirds of patients are asymptomatic, most of which are diabetic patients. Non-invasive angiological and microrheological tests on diabetic subjects
Katalin Biró, Barbara Sándor, Kinga Tótsimon, Katalin Koltai, Krisztina Fendrik, Dóra Endrei, Judit Vékási, Kálmán Tóth, Gábor Késmárky   +8 more
doaj   +2 more sources

Revascularization of Peripheral Arteries in Patients with Intermittent Claudication Decreases Inflammatory Biomarkers [PDF]

Clinical and Applied Thrombosis/Hemostasis, 2023
Patients with intermittent claudication have significantly higher levels of inflammatory biomarkers, particularly interleukins, which is also a consequence of exercise limitation.
Pavel Poredoš MD, PhD, Peter Poredoš MD, PhD, Matija Cevc MD, Jawed Fareed PhD, Vinko Boc MD, PhD   +4 more
doaj   +2 more sources

Biomarker Analysis from the Compass Claudication Study – Rivaroxaban for Intermittent Claudication [PDF]

Clinical and Applied Thrombosis/Hemostasis
Introduction A prospective, randomized, multicenter study compared rivaroxaban 2.5 mg twice daily plus aspirin 100 mg once daily against aspirin 100 mg once daily alone in patients with peripheral artery disease and intermittent claudication.
Karen Falcão Britto MD, Roberto Augusto Caffaro MD, PhD, Giuliano Giova Volpiani MD, PhD, Maria Fernanda Portugal MD, PhD, Samantha Neves MD, PhD, Alexia Paganotti MD, Felipe Menegueti Pereira MD, Leandro Barile Agati PhD, Camilla M. Ribeiro PhD, Viviane Santana da Silva RN, Emily Krupa MD, Isabela Rodrigues Tavares MD, Fakiha Siddiqui PhD, Jawed Fareed PhD, Valeria Cristina Resende Aguiar MD, Walkiria Bernardi Hueb MD, PhD, John W. Eikelboom MD, Sonia S. Anand MD, Renato D. Lopes MD, PhD, Eduardo Ramacciotti MD, PhD   +19 more
doaj   +2 more sources

Current Management of Intermittent Claudication [PDF]

Advances in Surgery, 2023
Caitlin W Hicks, David Stonko
exaly   +2 more sources

Assessment of Walking Ability in Patients with Intermittent Claudication Using a Smartphone Accelerometer

Journal of Scientific Innovation in Medicine, 2021
Objectives: It is challenging to accurately monitor the progress of intermittent claudication patients during or after treatment. Furthermore, diagnostic tools for intermittent claudication are not always adequate to determine whether other diseases are ...
Mark Greveling, Maaike de Bondt, Feike Weijzen, Robert Geelkerken, Mark Vlutters, Fabio Catarinella, Janwillem Hinnen   +6 more
doaj   +1 more source

Illness perception, health literacy, self-efficacy, adherence and quality of life in patients with intermittent claudication – a longitudinal cohort study

BMC Nursing, 2023
Background Patients with intermittent claudication need lifelong treatment with secondary prevention to prevent cardiovascular events and progression of atherosclerotic disease.
Rebecka Striberger, Moncef Zarrouk, Christine Kumlien, Malin Axelsson   +3 more
doaj   +1 more source

Cystic adventitial degeneration of common femoral artery: An unusual case of intermittent claudication. Case report and literature review

Annals of Vascular Surgery - Brief Reports and Innovations, 2022
Non atherosclerotic diseases producing intermittent claudication in middle-aged men are rare, but they are an important minority. Cystic adventitial disease (CAD) is one of these entities; its more frequent location is the popliteal artery.
Gabriele Pagliariccio, Di Ilenia Sario, Filippo Gianfelice, Antonio Villani, Alberto Giansante, Enrico Franceschini, Guido Baiocchi, Vinicio Rizza, Luciano Carbonari   +8 more
doaj   +1 more source

Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial

Clinical and Applied Thrombosis/Hemostasis, 2022
Background The COMPASS trial demonstrated that in patients with peripheral arterial disease, the combination of rivaroxaban and aspirin compared with aspirin reduces the risk of major adverse limb events, but it is not known whether this combination can ...
Eduardo Ramacciotti MD, PhD, Leandro Barile Agati PhD, Giuliano Giova Volpiani MD, Karen Falcão Brito MD, Camilla Moreira Ribeiro PhD, Valéria Cristina Resende Aguiar MD, Lorenzo Storino Ramacciotti, Alexia Paganotti, Felipe Menegueti Pereira, Roberto Augusto Caffaro MD, PhD, Alexandre Fioranelli MD, PhD, Rogério Krakauer MD, Heron Rhydan Saad Rached, Nelson Wolosker MD, PhD, Sonia S. Anand MD, John W. Eikelboom MBBS, Renato Delascio Lopes MD, PhD   +16 more
doaj   +1 more source

The Bambuí health and aging study (BHAS). Prevalence of intermittent claudication in the aged population of the community of Bambuí and its associated factors

Arquivos Brasileiros de Cardiologia, 2001
OBJECTIVE: To assess the prevalence of intermittent claudication in the aged population of Bambuí, Brazil, and to identify the factors associated with this disease.
Valéria Maria de Azeredo Passos, Sandhi Maria Barreto, Henrique Leonardo Guerra, Josélia Oliveira Araújo Firmo, Pedro Guatimosim Vidigal, Maria Fernanda Furtado Lima-Costa   +5 more
doaj   +1 more source

Gait pattern in patients with peripheral artery disease

BMC Geriatrics, 2018
Background The aim of the present paper is to assess the gait pattern of patients with Peripheral Artery Disease (PAD). A more specific aim is to compare the gait pattern of PAD patients before and after the appearance of intermittent claudication ...
Maria Szymczak, Paweł Krupa, Grzegorz Oszkinis, Marian Majchrzycki   +3 more
doaj   +1 more source